Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: The BRIGHT randomized clinical trial

Citation metadata

Date: Apr. 7, 2015
Publisher: American Medical Association
Document Type: Report
Length: 47 words

Document controls

Main content

Abstract :

The study aims to evaluate and compare the efficacy and safety of bivalirudin as against heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction. The results indicate that the use of bivalirudin resulted in a decrease in adverse clinical events and outcomes.

Source Citation

Source Citation   

Gale Document Number: GALE|A413993115